Sclareol ameliorates liver injury by inhibiting nuclear factor-kappa B/NOD-like receptor protein 3-mediated inflammation and lipid metabolism disorder in diabetic mice
Conclusions: Our findings suggest that SCL improves diabetes-induced liver injury by alleviating the NF-κB/NLRP3-mediated inflammation and lipid metabolism disorder.PMID:38131326 | PMC:PMC10748632 | DOI:10.1177/03946320231223644
Source: International Journal of Immunopathology and Pharmacology - Category: Allergy & Immunology Authors: Leilei Tang Xuan Mei Mengling Ye Yang Liu Yujie Huang Jiawen Yu Lingdi Zhang Sheng Zhuge Guojun Jiang Jianjun Zhu Source Type: research
More News: Allergy & Immunology | Antidoxidants | Diabetes | Drugs & Pharmacology | Endocrinology | Liver | Men | Study | Urology & Nephrology